Clinical Trials Browser

Unknown × Nivolumab × Sarcoma × Clear all

NCT04741438 2023-08-30

RAR-Immune

Phase 3 Unknown

Sarcoma

NCT05224999 2022-02-04

Nivolumab for Recurrent/Metastatic Carcinosarcoma

Phase 2 Unknown

Carcinosarcoma

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Phase 2 Unknown

GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor